←
Biogen6,027 posts
Biogen avatar

Biogen

@biogen

Official global newsroom account for Biogen, a leading biotech company pioneering innovative science since 1978. Community guidelines: bit.ly/1MZocKs

◷ Joined June 2010▧ 2,031 Photos and videos
Biogen avatar
Biogen@biogen·2h

#News: New real-world evidence in early Alzheimer’s disease in partnership with Eisai covers treatment pathways, sex-based outcomes and at-home administration. Learn more: spr.ly/6016Byn9sK #CTAD2026

0:10
Biogen avatar
Biogen@biogen·20h

#News: Today at #CTAD2026, we shared new two-year results from a Phase 2 study evaluating our investigational therapy targeting tau in early Alzheimer’s disease. Read more: spr.ly/6013Bypo21

0:16
Biogen avatar
Biogen@biogen·Nov 16

#News: Today at #CTAD2026, we presented initial five-year follow-up data in early Alzheimer's disease, including clinical outcomes, disease progression, and safety. Read more: spr.ly/6019Byru0H

0:10
Biogen avatar
Biogen@biogen·Nov 9

We're at @ACRheum (#ACR26) Convergence presenting new data in systemic lupus erythematosus (SLE). Stop by booth #4304 to learn how we aim to develop potential new options for people living with this chronic autoimmune disease.

Post attachmentPost attachment
Biogen avatar
Biogen@biogen·Nov 9

#News: At the American College of Rheumatology (ACR) Convergence we announced data for an investigational therapy for people living with systemic lupus erythematosus (SLE). Read more: bit.ly/4BW2dTu

0:07
Biogen avatar
Biogen@biogen·Nov 6

Join us at #ACR26 for a discussion where experts will explore why early conversations about reproductive goals, sustained disease control, and coordinated multidisciplinary care are critical to supporting informed decision-making.

Post attachment
Biogen avatar
Biogen@biogen·Nov 5

We’re headed to Atlanta for #ICAR2026, where we’re sharing updates from our ongoing research in Friedreich ataxia (FA). Find us at booth #304 to learn more about the impact of disease progression in people living with FA.

0:08
Biogen avatar
Biogen@biogen·Nov 5

We're heading to #BIOEurope! Join our panel discussion to hear insights on advancing innovation, strategic partnerships, and the shifting global landscape. Learn about our partnering opportunities across the globe: spr.ly/6010BHFy1o

Post attachment
Biogen avatar
Biogen@biogen·Nov 2

We’re headed to #NEI2026 in Colorado Springs! Together with Supernus Pharmaceuticals, we’ll present new real-world evidence on patient-reported outcomes in postpartum depression (PPD). Attending? Visit our medical booth #701 to connect with our team.

0:05
Biogen avatar
Biogen@biogen·Oct 29

#News: Massachusetts roots, global impact. We’re proud to be in our home state for #CTAD2026, presenting new data from our Alzheimer’s disease portfolio. Read about our upcoming presentations: spr.ly/6010BHmQGY

0:16
Biogen avatar
Biogen@biogen·Oct 21

At @ASNKidney #KidneyWk we’re presenting the latest data across our kidney disease portfolio. Stop by booth #588 and join us at our medical symposiums to learn about our ongoing work to address the unmet needs of this community.

Post attachmentPost attachment
Biogen avatar
Biogen@biogen·Oct 16

#News: Biogen New Ventures is proud to participate in the Series A financing of Estuary Biotherapeutics, a company pioneering targeted gene therapies for autosomal dominant polycystic kidney disease (ADPKD). Learn more: spr.ly/6012BHzBe4

0:06
Biogen avatar
Biogen@biogen·Oct 14

#News: Biogen New Ventures is proud to participate in Altay Therapeutics' Series A financing to support the development of an investigational oral therapy for facioscapulohumeral muscular dystrophy (FSHD). Learn more: bit.ly/4s2mBgW

0:06